PCBL Chemical Limited
Our verdict
Valuation (77/100) does the heavy lifting; financial trend (9/100) is the drag.
Our fair value
Undervalued by 37%Buy-below (20% margin of safety): ₹298.27
Our blended model reads PCBL Chemical Limited as a Sell at 33/100. We put fair value near ₹372.84; at ₹271.55 that leaves roughly 37% upside, so the stock screens undervalued by 37%. On 61.4x trailing earnings it sits pricier than the Chemicals median of about 41.0x. The price is about 25% below its 52-week high of ₹360.66 and 19% above the low of ₹228.95. Financial health scores 25/100, in the grey band on the Altman Z-score, with a Piotroski F-score of 5/9. The average analyst target of ₹339.82 implies about 25% upside across 11 analysts. It clears 3 of 13 investability checks, with durability 16, valuation 54 and momentum 14 on our 0–100 scales.
Analysis by Ankit Sharma · TickerMagic's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹298.27.
Analyst views
1-year price
EOD · 2026-11-2052-week range
-24.71% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell33Piotroski F-score 5/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 5.1%
- Fail: Low debt (D/E < 0.5): 1.24x
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: -1%
- Fail: Earnings growing: -61%
- Fail: Net margin ≥ 10%: 2.4%
- Fail: Current ratio > 1.5: 0.83
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z 1.99
- Fail: Piotroski ≥ 7: 5/9
Quarterly results
Annual financials
Shareholding
- Promoter7.1%
- Institutions63.1%
- Public & other29.8%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Opportunities
- Trades ~37% below our estimated fair value.
Bear case
Weaknesses
- Low return on equity (5.1%).
- High debt relative to equity.
- Price below its 200-day moving average (downtrend).
Threats
- Earnings contracting year on year.
About PCBL Chemical Limited
PCBL Chemical Limited manufactures and exports carbon black through operations across India and international markets. The company segments its business into Carbon Black, Power, Chemicals, and Battery Chemical divisions, offering products under brands including CarboNext, ECOZEN 6000, Royale Black, Bluemina, NuTone, and Energia for applications in tires, performance chemicals, specialty chemicals, and other materials.
PCBL Chemical Limited — frequently asked questions
Is PCBL Chemical Limited a buy, hold or sell?
TickerMagic currently rates PCBL Chemical Limited (PCBL) a Sell, based on a blended score of 33/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is PCBL Chemical Limited's fair value?
Our blended DCF and relative-valuation model estimates PCBL Chemical Limited's fair value at about ₹372.84, versus a current price of ₹271.55 — roughly 37% upside. On that basis the stock looks undervalued by 37%.
Is PCBL Chemical Limited financially healthy?
PCBL Chemical Limited scores 25/100 on our financial-health model, placing it in the grey band on the Altman Z-score, with a Piotroski F-score of 5/9.
How has PCBL Chemical Limited's share price performed?
PCBL Chemical Limited is down 17% over three months, and last traded at ₹271.55. Past performance doesn't predict future returns.
More in Chemicals
Our verdict, fair value, financial-health and checklist are TickerMagic's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.